September 16/18, 2007

ROMEUniversità Urbaniana

THE MEETING IS ORGANIZED BY

OLTRE LA NUTRIZIONE - onlus

SOMED – The Society of Microbial Ecology in Health & Disease

Under the patronage of

Azienda Complesso Ospedaliero “San Filippo Neri” - RomaFIMAD (Federazione Italiana Malattie Apparato Digerente)

FISM (Federazione delle Società Medico-Scientifiche Italiane)INRAN (Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione)

ISS (Istituto Superiore di Sanità)Ministero della Salute (requested)

“Sapienza” Università di Roma, II Facoltà di Medicina e Chirurgia

1

3

4TH PROBIOTICS, PREBIOTICS & NEW FOODS

CHAIRSL. Capurso ItalyG. Delle Fave ItalyL. Morelli Italy

SCIENTIFIC COMMITTEEP. Aureli ItalyC. Cannella ItalyN. Caporaso ItalyR. Caprilli ItalyG.V. Coppa ItalyC. Cricelli ItalyW.M. de Vos The NetherlandsM. Del Piano ItalyM. Floch USAV. Fogliano ItalyA. Gasbarrini ItalyG. Gasbarrini ItalyS.L. Gorbach USAS. Guandalini USAA. Guarino ItalyE. Isolauri FinlandM. Koch ItalyJ.R. Malagelada SpainF. Marotta ItalyT. Mattila-Sandholm FinlandM. Miraglia del Giudice ItalyF. Pallone ItalyE. Quigley USAG. Reid CanadaA. Saggioro ItalyA. Salminen FinlandM.E. Sanders USAE. Schiffrin SwitzerlandB. Shenderov Russia

XXX SOMED MEETING

CHAIRSG. Donelli ItalyB.L. Jacobsen DenmarkT. Midtvedt Sweden

SCIENTIFIC COMMITTEEJ.M. Antoine FranceE. Bertazzoni Minelli ItalyE. Bezirtzoglou GreeceP. Borriello U.K.P. Brigidi ItalyA. Collignon FranceG. Corthier FranceC. De Simone ItalyG. Fadda ItalyS. Kamiya JapanD. Kitz USAK. Krogfelt DenmarkP. Mastrantonio ItalyD. Matteuzzi ItalyT. Mazzei ItalyM. Mikelsaar EstoniaR. Mollby SwedenG. Nicoletti ItalyE. Norin SwedenA. Novelli ItalyI. Olsen NorwayA. Onderdonk USAG. Pozzi ItalyC. Pruzzo ItalyG.M. Rossolini ItalyG. Russo ItalyK. Scott U.K.L. Vieira Brazil

LOCAL SCIENTIFIC SECRETARIATG. Capurso (Italy), M. Marignani (Italy), A. Moretti (Italy), E. Guaglianone (Italy)

03.00 - 04.00 p.m. Opening Ceremony L. Capurso (Italy)G. Donelli (Italy)

Welcome Addresses G. Cornaglia (Italy)European Society of Microbiology and Infectious Diseases, PresidentE. Garaci (Italy)Italian National Institute of Health (ISS), PresidentC. Cannella (Italy)Italian National Research Institute on Foods and Nutrition (INRAN), President

04.00 - 05.00 p.m. Chairpeople: G. Delle Fave (Italy) – L. Morelli (Italy)

LECTURES IN HONOUR OF:

Henry Tissier: the man in the shadow let us get him out in the sunT. Midtvedt (Sweden)

Elie Metchnikoff: the optimistic philosopherL. Morelli (Italy)

Minoru Shirota: the philosophy of prevention rather than curing F. Dellaglio (Italy)

05.00 - 06.30 p.m. PRESENTATION OF DATA OFFAO TECHNICAL MEETING ON PREBIOTICSChairpeople: M. Pineiro – L. Morelli – L. Capurso (Italy)

WELCOME COCKTAIL

4

sunday, September 16 - aul a magna

04.00 - 05.30 p.m. POTENTIAL ROLE OF NATURAL ANTIOXIDANTS IN THE PREVENTION OF SOME HUMAN DISEASES Chairpeople: G.L. Gianfranceschi (Italy) – F. Marotta (Italy)

Development of biomarkers of oxidative stress and inflammation to predict the effects of natural antioxidantsP. Patrignani (Italy)

Many dietary plants and fruits are popularly claimed to be source of strong cocktails of antioxidant and antinflammatory compounds. But is it always true ?G.L. Gianfranceschi (Italy)

Nutrition and cardiovascular diseaseG. Lupattelli (Italy)

Redox status and oxidative stress prevention: how should we "eat" our antioxidants ?M. Serafini (Italy)

Nutraceuticals and the challenge of genomic-drivenage-management F. Marotta (Italy)

05.30 - 07.00 p.m. FUNCTIONAL FOOD PREPARATIONS: CLAIMS ON FUNCTIONALITY,TECHNOLOGICAL ISSUES, SAFETY AND EFFICACYChairpeople: B. Lund Jacobsen (Denmark) – D. Matteuzzi (Italy)

Antibiotic susceptibility of bacteria isolates from probiotic products available in ItalyG. Blandino (Italy)

An antimicrobial and antioxidative probiotic: claims for double benefitM. Mikelsaar (Estonia)

How bifidobacterial genomics could help in understanding probiotic functionalityM. Ventura (Italy)

Human intestinal microbiota and nutrition homeostasisB.A Shenderov (Russia) - V.A. Aleshkin (Russia)

Relationship between number of bacteria and their probiotic effectsE. Bertazzoni Minelli (Italy)

5

sunday, September 16 - aul a newman

08.30 - 11.00 a.m. STATE OF ART Chair: T. Mattila - Sandholm (Finland)

Functional genomics of probiotic bacteriaT. Klaenhammer (USA)

Metagenomics of the intestinal microbiotaJ. Doré (France)

Interactomics in the human intestineW.M. de Vos (The Netherlands)

Omics Opening new x-biotics markets ?Panel Discussion featuring Contributions of:A Bifidobacteria Case - A. Mercenier (Switzerland)The Case of Lactobacillus GG - S. Tynkkynen (Finland)The Microbiota Case - L. Morelli (Italy)

11.00 - 12.00 a.m. PROBIOTICS AND CANCER CHEMIOTHERAPYChairman: M. Crespi (Italy)

Chemiotherapy and intestinal microflora in cancer patientsG. Biasco (Italy)

Cancer gene therapy with anaerobic and non pathogenic bacteriaA. Saggioro (Italy)

12.00 - 01.30 p.m. IMMUNE RESPONSE MODULATION PLAYED BY NEW CONCEPT PROBIOTICS Chairpeople: L. Morelli (Italy) – E. Grossi (Italy)

Dendritic cells and probiotics in intestinal immune homeostasis M. Rescigno (Italy)

Lactobacillus paracasei strain B 21060 and human T Cell proliferation F. Caprioli (Italy)

Lactobacillus paracasei strain B 21060 and cytokine production in patients with ulcerative colitisM. Romano (Italy)

LUNCH

02.30 - 04.30 p.m. IBD President: R. Caprilli (Italy)Chairpeople: F. Pallone (Italy) - C. Prantera (Italy)

LECTUREProbiotics and IBDM. Gassul (Spain)

6

Monday, September 1 7 - aul a magna

Innate immunity and IBDS. Danese (Italy)

Solute carriers (SLC) in inflammatory bowel disease, a potentialtarget for probiotics ?M. D'Amato (Italy)

Understanding the why probiotic therapy can be effective in treating IBDR. Fedorak (Canada)

Saccharomyces boulardii and IBDM. Guslandi (Italy)

Probiotics in arthralgia and spondyloarthropathies in IBDA.S. Peña (The Netherlands)

04.30 - 06.00 p.m. ANTIBIOTICS AND ALTERATIONS IN INTESTINAL FLORA Chairpeople: P. Mastrantonio (Italy) – K. Scott (U.K.)

The hypervirulent antibiotic-resistant Clostridium difficile in EuropeP. Mastrantonio(Italy)

The gnotobiotic mouse model to study the effects of antibiotics on human fecal floraA. Collignon (France)

Antibiotic susceptibility of Bifidobacterium strainsM. Saarela (Finland)

Transfer of ermB-PLASMID from Lactobacillus to Enterococcus faecalis in the intestine of gnotobiotic ratsL. Feld (Denmark)

Identification and molecular analysis of tetracycline and erythromycin resistance genes from lactic acid bacteria isolatedfrom an Italian dairy productC. Devirgiliis (Italy)

06.00 - 06.30 p.m. LECTUREImprovement of microflora balance and gut functionality by probioticsF. Marotta (Italy)

06.30 - 07.30 p.m. PROBIOTIC IN HUMAN DISEASESChairpeople: C. Cricelli (Italy) – M. Koch (Italy)

Probiotics and IBSM. Camilleri (USA)

Probiotics in critically ill patients K. Madsen (Canada)

Probiotics improve liver injury in nonalcoholic steatohepatitis in an animal model of sedentary lifestyle S.H. Abrams (USA)

7

Monday, September 1 7 - aul a magna

08.30 - 10.30 a.m. MICROBIAL ECOLOGY AND HUMAN HEALTH Chairpeople: E. Bezirtzoglou (Greece) – C. Pruzzo (Italy)

LECTUREProbiotic lactobacilli for urogenital health in womenG. Reid (Canada)

Adhesins selected in the environment and bacterial pathogenecityC. Pruzzo (Italy)

Emerging antimicrobial resistance in environmental aquatic ecosystems and foodsE. Bezirtzoglou (Greece)

Role of vaginal lactobacilli in the prevention of sexually transmitted viral infectionsP. Mastromarino (Italy)

Colonization of rectal and vaginal epithelium by 3 different Lactobacillus strains given orally P. Heczko (Poland)

10.30 - 11.15 a.m. CELIAC DISEASEChairman: G.R. Corazza (Italy)

The celiac disease and the intestinal microfloraE. Norin (Sweden) – T. Midtvedt (Sweden)

Antiantagonistic effect of a naturally occurring peptide in celiac diseaseM. De Vincenzi (Italy) – M. Silano (Italy)

11.15 - 12.15 a.m. LECTURESChairman: M. Del Piano (Italy)

Is a microbiologist potentially helpful in IBS?

L. Morelli (Italy)

Microbiological characteristics of some Italian probiotics L. Drago (Italy)

12.15 - 01.30 p.m. MICROBIAL BIOFILMS AND HUMAN INFECTIONSChairpeople: G. Donelli (Italy) – S. Molin (Denmark)

Microbial biofilms in the human gastrointestinal tractS. Macfarlane (U.K.)

Switch from planktonic life to biofilm formation: a major event in pneumococcal pathogenesisM.R. Oggioni (Italy)

The role of multispecies microbial biofilms in the occlusion of biliary stentsE. Guaglianone (Italy)

A new bacterial biofilm model for the chronic CF lung infectionsS. Molin (Denmark)

LUNCH

8

Monday, September 1 7 - aul a newman

03.00 - 04.30 p.m. NEW MOLECOLAR TARGET FOR FUNCTIONAL FOODS EFFICACY Chairman: V. Fogliano (Italy)

Gene expression and cell signalling modulation of oxysterolsG. Poli (Italy)

Effects of vegetal foods and molecular biomarkersM. Porrini (Italy)

Post-prandial glucose and insulin response is improved by bread fortified with germinated wheat seedlingsV. Somoza (Germany)

Towards functionally enhanced prebioticsR.A. Rastall (USA)

04.30 - 06.00 p.m. USE OF NEW FOODS IN EXPERIMENTAL AND HUMAN STUDIES Chairman: N. Caporaso (Italy)

Whole grain health benefit: the human studiesA. Costabile (U.K.)

Role of carnitine in butyrate metabolismG. D'Argenio (Italy)

Functional milk as adjuvants to pharmacological therapy of chronic hepatitis C F. Morisco (Italy)

Satiating effect of a new fiber-rich foodP. Vitaglione (Italy)

06.00 - 07.00 p.m. DIET VERSUS DRUGS IN DYSLIPIDEMIAS Chairman: G. Spera (Italy)

Simvastatin alone or simvastatin plus ezetimibe versusdiet in dyslipidemiasM. Averna (Italy)

Lipid metabolism and bowel health: an up date on knowledge about probiotic/prebiotic supplementation and cholesterol metabolismA.F.G. Cicero (Italy)

Plant sterols … from research to practiceE. Roda (Italy)

9

Monday, September 1 7 - aul a Newman

Ped iatr ic dayChairpeople: A. Guarino (Italy) - B. Koletzko (Germany)

08.30 - 10.30 a.m. OPENING LECTUREThe role of microorganisms in the first year of life and the development of allergyA. Onderdonk (USA)

ROUND TABLEAGE-RELATED NUTRITIONAL APPROACH

The nutritional modulation of the evolving intestine R. Berni Canani (Italy) - A. Guarino (Italy)

Functional compounds in the newborn formula O. Hernell (Sweden)

The ESPGHAN recommendations for infant formula B. Koletzko (Germany)

Toward the European indications for complementary feeding C. Agostoni (Italy)

10.30 - 12.00 a.m. ROUND TABLE CLINICAL EFFECTS BY FUNCTIONAL FOODS IN INFANT FORMULAChairpeople: C. Lifshitz (USA) - G.V. Coppa (Italy)

Probiotics in infant formula W. Mihatsch (Denmark)

Which role for prebiotics in weaning?

S. Fanaro (Italy) - V. Vigi (Italy)

Zinc and lactoferrin as trophic factors V. Buccigrossi (Italy)

Short and long term effects of LC PUFAT. Decsi (Hungary)

10

monday, September 1 7 - aul a c - Ped iatr ic day

12.00 - 12.30 a.m. LECTUREDoes fecal microbiota predict obesity?

E. Isolauri (Finland)

LUNCH

03.00 - 04.30 p.m. SYMPOSIUM PROBIOTICS AND ALLERGYChairman: M. Miraglia del Giudice (Italy)

Probiotics, prebiotics and allergy in children: what news in the last year ?M. Miraglia del Giudice (Italy)

Probiotics and allergic rhinitis in children G. Ciprandi (Italy)

Probiotics and immune system … beyond the probiotics A. M. Castellazzi (Italy)

Allergen free probioticsL. Mogna (Italy)

04.30 - 06.00 p.m. LECTURESPROBIOTICS AND GI DISEASESChairman: C. Agostoni (Italy)

Up to date on research of Lactobacillus ReuteriE. Connolly (Sweden)

A randomized double blind trial with probiotic VSL #3 in acuterotavirus diarrhoea among children: “The Indian experience”A. Prakash Dubey (India)

Eradication terapy of HP: the effect of lactobacillus reuteri E. Lionetti (Italy)

Probiotic bacteria for treatment of gastroenteritisJ. Amil Dias (Portugal)

11

monday, September 1 7 - aul a c - ped iatr ic day

06.00 - 07.00 p.m. PEDIATRIC STUDIESChairman: M. Miraglia del Giudice (Italy)

METABOLIC FATE OF HUMAN MILK OLIGOSACCHARIDES IN FOUR DIFFERENT GROUPS OFMILK IN BREASTFED INFANTSG.V.Coppa, L.Zampini, L.Padella, S.D'Egidio, O.GabrielliInstitute of Maternal-Infantile Sciences - Polytechnic University of Marche

SUCCESSFUL THERAPY OF UNSPECIFIC PROLONGED DIARRHOEA IN INFANTS ANDTODDLERS WITH THE PROBIOTIC E. COLI NISSLE 1917J Henker§, B.M. Blokhin*, Y.K. Bolbot**, V.G. Maydannik***, C. Wolff****, Lothar Schulze****

§ Dept. of Paediatrics, University Hospital, Fetscherstraße 74, 01307 Dresden, Germany*Outpatient pediatrics,Russian State Medical University Akademika, Moscow, Russia** Pediatrics No 2, Dnepropetrovsk State Medical Academy, Dnepropetrovsk, Ukraine***Pediatrics No 4, City Pediatric Clinical Hospital No 6, National Medical University O.O. Bogomolets, Kyiv, Ukraine ****Ardeypharm, Herdecke, Germany

POTENTIAL PREBIOTIC EFFECT OF ALMOND (Amygdalus communis L) SEEDSG. Mandalari*,**, C. Nueno-Palop*, R. Faulks*, G. Bisignano**, A. Narbad*, MSJ. Wickham*

*Institute of Food Research, Norwich NR47UA (UK)**Dip. Farmaco-Biologico, Universita’ di Messina,(Italy)

PROBIOTICS REDUCE INCIDENCE AND DURATION OF RESPIRATORY TRACT INFECTIONSYMPTOMS IN 3-5 YEAR OLD CHILDRENA.C. Ouwehand*, D. Carcano*, S. Li***, G. Leyer****

*Danisco Cultures, 02460 Kantvik, Finland**Danisco Cultures, 75017 Paris, France***Medical College of Tongji University, 200092 Shanghai, P.R. China ****Danisco Cultures, WI 53716 Madison, USA

SPECIFICITIES OF THE FAECAL MICROBIOTA OF COELIAC CHILDREN Sanz Y.*; Sánchez E.*; Marzotto M.**; Nadal I.*; De Palma G.*; Ribes C***; Calabuig M.****; Torriani S.**, and Dellaglio F.**

*Instituto de Agroquímica y Tecnología de Alimentos (CSIC), Apartado 73, 46100 Burjassot, Valencia, Spain. **Department of Science and Technology, University of Verona, Strada Le Grazie, 15 - 37134 Verona, Italy. ***Hospital Universitario La Fe, Avenida Campanar 21, 40009 Valencia, Spain.**** Hospital General Universitario, Avenida Tres Cruces s/n 46014 Valencia, Spain.

REDUCED DIVERSITY IN THE EARLY FECAL MICROBIOTA OF INFANTS DEVELOPING ATOPICECZEMAM. Wang*, C. Karlsson*, C. Olsson*, I. Adlerberth**, A. Wold**, D.P. Strachan***, P. M. Martricardi****,N. Åberg*****, M.R. Perkin***, S. Tripodi******, A.R. Coates*******, B. Hesselmar*****, R. Saalman*****,G. Molin*, S. Ahrné*

*Deptartment of Food Technology, Engineering and Nutrition, Lund University, Sweden**Dept. of Clinical Bacteriology, Göteborg University, Sweden,***Division of Community Health Sciences, St. George's, University of London, UK,****Department of Pediatric Pneumology and Immunology, Charite Medical University, Berlin, Germany,*****Dept. of Paediatrics, Göteborg University, Sweden,******Dept of Paediatrics, Pertini Hospital, Rome, Italy,*******Medical Microbiology, Department of Cellular & Molecular Medicine, St. George's, University of London, UK.

12

monday, September 1 7 - aul a c - ORAL COMMUN IC AT IONS

5th probiotics prebiotics new foods

&

September 2009

ROME

S A V E THE DATE

08.30 - 10.30 a.m. EXPERIMENTAL STUDIES (I)Chairpeople: P. Brigidi (Italy) - M. Mikelsaar (Estonia)

PREBIOTIC OLIGOFRUCTOSE PROTECTS AGAINST INSULIN RESISTANCE AND METABOLICDISEASE IN HIGH-FAT FED MICE.P.D. Cani1, A. Neyrinck1, F. Fava2, C. Knauf3, R. Burcelin3, K.M. Tuohy2, G.G. Gibson2 and N.M. Delzenne1

1Unit of Pharmacokinetics, Metabolism, Nutrition and Toxicology, Université Catholique de Louvain, Brussels, Belgium. 2FoodMicrobial Science Unit, Department of Food Bioscience, University of Reading, Reading, United Kingdom. 3Rangueil Institute ofMolecular Medicine, I2MR, IFR31 Toulouse, France.

METABONOMIC INVESTIGATION INTO THE INFLUENCE OF GUT MICROBIOTA ONMETABOLIC PHENOTYPESS.P. Claus, T.M. Tsang, Y. Wang, E. Holmes, J.K. NicholsonDepartment of Biomolecular Medicine, SORA division, Imperial College London, Sir Alexander Fleming Building, SouthKensington, London SW7 2AZ, UKF. Martin, S. Rezzi, A. Ross, S. KochharBioAnalytical Science Department, Nestlé Research Center, P.O. Box 44, CH-1000 Lausanne 26, Switzerland

PROBIOTICS PREVENT DEATH CAUSED BY CITROBACTER RODENTIUM INFECTION IN NEONATAL MICE M.G Gareau, E. Wine, K.C. Johnson-Henry, M.H. Perdue* and P.M. Sherman. Department of Cell Biology, The Hospital for Sick Children, Toronto, ON, CANADA; *Intestinal Disease Research Programme,McMaster University, Hamilton, ON, CANADA

FAECALIBACTERIUM PRAUSNITZII, A MAJOR COMMENSAL BACTERIUM, EXHIBITS ANTI-INFLAMMATORY EFFECTS IN CELLULAR MODELS AND TNBS-INDUCED MURINE COLITISH. Sokol*, B. Arnaud-Pigneur**, L. Watterlot*, O. Lakhdari*, H. Blottière*, C. Grangette****,G. Trugnan**, J. Doré*, G. Thomas**, P. Marteau***, P. Seksik** and P. Langella*

* UEPSD, INRA, Jouy-en-Josas, ** INSERM U538 Pierre & Marie Curie University Paris VI, *** Gastroenterology Unit, LariboisièreHospital APHP, Paris, **** Laboratoire de Bactéries Lactiques et Immunité des Muqueuses, Institut Pasteur de Lille

THE INTERFERENCE BETWEEN CELL FREE LACTIC ACID BACTERIA CULTURE SUPERNATANTSWITH THE EXPRESSION OF VIRULENCE.FACTORS OF STAPHYLOCOCCUS AUREUS ANDPSEUDOMONAS AERUGINOSA CLINICAL STRAINS V. LazarUniversity of Bucharest,Faculty of Biology

ACID STRESS RESPONSES OF PROBIOTICS LACTOBACILLUS CASEI AND LB. PARACASEIM. Hosseini Nezhad*, M. Knight**, M.L. Britz***

*Faculty of Land and Food Resources, University of Melbourne, Australia, **Animal Genimics, Primary Industries ResearchVictoria, Australia, ***Faculty of Science, Queensland University of Technology, Australia

EFFECT OF PROBIOTIC BACTERIA ON A PORCINE CELL MODEL WITH INTESTINAL EPITHELIALCELLS AND BLOOD MONOCYTESL. Nissen*, W. Chingwaru**, B. Sgorbati*, B. Biavati*, A. Cencic**

*Department of Agroenvironmental Science and Technology, Microbiology Area, Alma Mater Studiorum, V.le Fanin 44, 40132Bologna, Italy., ** Department of Microbiology, Biochemistry and Biotechnology, Univerza v Mariboru, Magdalenski trg 5, 2000Maribor, Slovenija.

EFFECTS OF A BICARBONATE-ALKALINE MINERAL WATER ON GASTROINTESTINAL MOTILITYIN EXPERIMENTAL MODELS OF INTESTINAL INFLAMMATIONM. Fornai, L. Antonioli, R. Colucci, N. Ghisu, M. Tuccori, C. Blandizzi, M. Del TaccaIstituto Farmacologia,Università di Pisa,Italy

14

monday, September 1 7 - aul a d - ORAL COMMUN IC AT IONS

ISOLATION FROM RAW MILK OF LACTIC ACID BACTERIA POTENTIALLY RESISTANT TOUPPER GASTRO-INTESTINAL TRACT.Baruzzi F.*, Castellano L.*, Poltronieri P.**, Quero G.M.* and Morea M.*

Institute of Sciences of Food Production – CNR – *V. G. Amendola 122/o, 70126 Bari, ITALY Via Prov.le Lecce-Monteroni,73100 Lecce, ITALY

IN VITRO ANALYSIS OF PROBIOTIC STRAIN COMBINATIONS AGAINST PATHOGENADHESION TO HUMAN INTESTINAL MUCUSM.C. Collado°, J. Meriluoto**, S. Salminen*

*Functional Foods Forum, University of Turku, Itäinen Pitkäkatu 4A, 20014 Turku, Finland, **Department of Biochemistryand Pharmacy, Åbo Akademi University, Tykistökatu 6A,20520 Turku, Finland

11.00 - 12.30 a.m. CLINICAL STUDIES Chairpeople: A. Andriulli (Italy) - P. Paoluzi (Italy)

EFFECT OF OLIGOFRUCTOSE-ENRICHED INULIN ON BODY WEIGHT DURING PUBERTALGROWTHS.A. Abrams*, I.J. Griffin*, K.M. Hawthorne*, K.J. Ellis*, D. Bosscher?, A. Franck?

* USDA/ARS Children's Nutrition Research Center, and Texas Children's Hospital, Department of Pediatrics, Baylor Collegeof Medicine, Houston, Texas; ? ORAFTI Group, Tienen, Belgium

CLINICAL EFFICACY OF A NEW PROBIOTIC FORMULATION, FLORTEC®, IN PATIENTS WITHIRRITABLE BOWEL SYMPTOMS. A MULTICENTER, RANDOMIZED STUDYA. Andriulli*, M. Neri**, C. Loguercio***, N. Garbagna****, R. Cerutti****, E. Grossi**** for the Flortec Group*Casa di Cura “Sollievo della Sofferenza” S. Giovanni Rotondo (FG); **University of Chieti; ***University of Naples;****Flortec Group Bracco

EFFECT OF GLUTEN-FREE DIET ON FAECAL MICROFLORA COMPOSITION OF WOMENWITH CELIAC DISEASEE. Bertazzoni Minelli, A. Benini, C. Ciacci*Dpt. Medicine and Public Health, Pharmacology Section, University of Verona; * Dpt. Clinical and Experimental Medicine,Gastroenterology, University of Naples Federico II, Naples, Italy

COLONIC ADENOMA SURFACE CELLS MODULATION OF LOCAL MICROFLORA: APOTENTIAL FACTOR OF TUMOUR PROGRESSION*Pagnini C., *Corleto V.D., Torre M.S., Attilia F., D'Ambra G., Di Giulio E., Delle Fave G.Dip. Malattie Apparato Digerente e Fegato, II Facoltà di Medicina e Chirurgia, Università "La Sapienza", *Centro RicercheFatebenefratelli, Ospedale S. Pietro, Roma

VAGINAL PROBIOTIC ACTION THAT CONTENT A Lactobacillus acidophilus STRAIN INWOMEN WITH VAGINOSISE. Castro, L. Perez, M. Sanchez, A. Solis. J. Ferrer, C. Melo, A. Rodriguez, J. Madariaga, R. BorquezLaboratorio de Bacterias Lácticas, Universidad de Concepción, Chile

IMPACT OF A FUNCTIONAL FOOD CONTAINING FOS, ON THE GUT MICROFLORA OFHEALTHY VOLUNTEERS: A RANDOMISED, DOUBLE-BLIND, PLACEBO CONTROL TRIALE Mitsou, K Turunen, P Anapliotis, D Zisi and A Kyriacou*

Harokopio University, Athens, Greece

15

monday, September 1 7 - aul a d - ORAL COMMUN IC AT IONS

BUTYRIC ACID AND IBS SYMPTOMS: A PILOT STUDYS. Carmagnola*, M. Del Piano*, A. Saggioro**,. L. Capurso***

Gastroenterology Unit, "Maggiore della Carità" Hospital, Novara, Italy; **Digestive Diseases, Hepatology and Clinical NutritionDepartment, Umberto I Hospital, Venice, Italy, ***Department of Gastroenterology, S. Filippo Neri Hospital, Rome, Italy

MICROBIOLOGY OF ROOT CARIES IN ELDERLYD. Preza*, J.A. Aas*,T. Willumsen*, B. Paster**, B. Grinde***, A. I. Olsen*

*University of Oslo, Faculty of Dentistry, Norway, ** Forsyth Institute, Boston, MA, USA, *** Norwegian Institute of Public Health, Oslo, Norway

PROBIOTICS MAINTAIN MUCOSAL BARRIER INTEGRITY IN EXPERIMENTAL ACUTE PANCREATITISVIA STABILISATION OF TIGHT JUNCTIONS AND ENHANCEMENT OF MUCOSAL GLUTATHIONEF. Lutgendorff*,**, P.A. Sandström*, L.M. Trulsson*, L.P. van Minnen**, G.T. Rijkers**, H.M. Timmerman**,H.G. Gooszen**, L.M.A. Akkermans**, J.D. Söderholm*

*Department of Surgery, University Hospital, Linköping, Sweden; **Department of Surgery, University Medical Center, Utrecht, TheNetherlands

BALSALAZIDE PLUS VSL#3 FOR THE TREATMENT OF ULCERATIVE COLITIS AND COLONICDIVERTICULITIS: A CLINICAL EXPERIENCEA. Tursi Digestive Endoscopy Unit, “Lorenzo Bonomo” Hospital, Andria (BA) – Italy

CURCUMIN VS DOMPERIDONE IN FUNCTIONAL DYSPEPSIA: AN OPEN, RANDOMIZED, TRIALA. Nouvenne(1), L.G. Cavallaro(2), A. Maini(1), L. Guida(1), R. Merli(1), E. Morana(1), L. Martelli(3), M.Martelli(3), A. Franzè(2), F. Di Mario(1)

(1)University of Parma department of clinical Sciences, Parma, Italy (2)Hospital of Parma, Gastroenterology Unit, Parma, Italy(3)University of Padova, Department of Chemistry, Padova, Italy

03.00 - 05.00 p.m. EXPERIMENTAL STUDIES (II)Chairpeople: E. Norin (Sweden) - C. Pruzzo (Italy)

COMMUNITY ORGANIZATION IN HUMAN COLON ECOSYSTEMS: SYMBIOTIC ASSOCIATIONSBETWEEN DOMINANT HUMAN FECAL STRAINS OF BACTEROIDES AND BIFIDOBACTERIA ANDSMALLER POPULATIONS OF E. COLI AND R. TORQUES IN A NUTRITIONALLY SPARSE CULTURE MEDIUML.C. Hoskins and C.J. DonskeyCase Western University and the Louis Stokes Veterans Affairs Medical Center, Cleveland, Ohio, 44106 USA

MICROBIAL PROFILE OF THE INTESTINAL MICROFLORA IN ICU PATIENTS FOLLOWINGSYNBIOTICS TREATMENTVoidarou C.(1), Kotzampassi K.(2), Voudouris A.(2), Alexopoulos A.(1)and Bezirtzoglou E.(1)

(1) Democritus University of Thrace, Department of Food Science and Technology, Laboratory of Microbiology, Biotechnology andHygiene, Orestiada, Greece(2) Aristotle University of Thessaloniki, Faculty of Medicine, Department of Surgery, Thessaloniki, Greece

EFFECTS OF INTRANASAL ADMINISTRATION WITH LACTOCOCCUS LACTIS SECRETING LEPTINON FOOD INTAKE, BODY WEIGHT AND IMMUNE RESPONSE IN MICEL.G. Bermúdez-Humarán*, S. Nouaille**,***, V. Zilberfarb**,***, G. Corthier*, A. Gruss****, P. Langella*, T. Issad**,**

*Unité d'Ecologie et de Physiologie du Système Digestif, INRA, Domaine de Vilvert, 78352 Jouy en Josas cedex, France. ** Institut Cochin, Université Paris Descartes, CNRS (UMR 8104), Paris, France. ***Inserm, U567, Paris, France.****Unité des Bactéries Lactiques et pathogènes Opportunistes, INRA, Domaine de Vilvert, 78352 Jouy en Josas cedex, France.

16

monday, September 1 7 - aul a d - ORAL COMMUN IC AT IONS

TRANSGALACTOOLIGOSACCHARIDES MODIFY MICROFLORA AND IMMUNE RESPONSEIN PEANUT-SENSITIZED MICEG. Leforestier, A.M. Davila-Gay, M. Dubarry, A. Blais, A. Marsset-Baglieri, D. ToméUMR914 Nutrition Physiology and Ingestive Behavior, INRA, AgroParisTech, 16 rue Claude Bernard, F-75005 Paris, France

EFFECT OF LACTOBACILLUS RHAMNOSUS GG ON HUMAN COLONIC SMOOTH MUSCLECELLS FOLLOWING MUCOSA EXPOSURE M. Guarino, S. Carotti, A. Altomare, M. Marignani*, C. Severi**, R. Alloni, L. Morelli***, F. Panzera,R. Coppola, M. Cicala Department of Digestive Disease, Dpt of Digestive Diseases of Campus Biomedico University, Rome, Italy, *Dpt of Gastrointestinaland Liver Disease, S.Andrea Hospital, Second Medical Faculty, “La Sapienza” Rome, Italy, **Dpt of Clinical Sciences, UniversityLa Sapienza, Rome, Italy, ***Microbiology Institute, UCSC Piacenza, Italy

METABOLIC PHENOTYPE AND METAGENOMIC (GUT MICROBIAL) ANALYSIS OF THEZUCKER RAT MODEL OF TYPE II DIABETESA. Waldram*, Y. Wang*, E. Holmes*, J.K. Nicholson*, I.D. Wilson**

* Biomolecular medicine, SORA Division, Faculty of Medicine, Imperial College London, South Kensington, SW7 2AZ, UK**AstraZeneca, Alderly Park, Mereside, Macclesfield, Cheshire, SK10 4TF, UK

REMOVAL OF CYANOBACTERIAL TOXINS BY SPECIFIC STRAINS OF PROBIOTIC BACTERIA S.M.K. Nybom*, S.J. Salminen**, J.A.O. Meriluoto*

*Department of Biochemistry and Pharmacy, Åbo Akademi University, Tykistökatu 6A, 20520 Turku, Finland,**Functional Foods Forum, University of Turku, 20014 Turku, Finland

EVALUATION OF THE PREBIOTIC POTENTIAL OF REFINED PSYLLIUM (PANTAGO OVATA)FIBRE IN HEALTHY WOMENM. Elli, E. Bessi, D. Cattivelli, S. Soldi, L. MorelliFacoltà di Agraria, Istituto di Microbiologia, Università Cattolica Sacro Cuore, Piacenza

17

monday, September 1 7 - aul a d - ORAL COMMUN IC AT IONS

09.00 - 10.30 a.m. PROBIOTICS: FROM APPLIED RESEARCH TOWARDS HEALTH BENEFITSChairman: V. Stanghellini (Italy)

Probiotics & host responses: towards new integrated approachesG. Grompone (France)

Can lactobacilli improve the potential of vaccinations?M. Remigy (France)

Probiotics and the hygyene hypothesisF. Salvini (Italy)

Can we impact gastrointestinal comfort? New data on Bifidobacterium animalis DN 173 010S. Jakob (France)

10.30 - 10.45 a.m. DICOFARM - AG PHARMA PRIZEPresentation of winners

10.45 - 12.00 a.m. INTESTINAL ECOLOGY: SUGGESTION FOR CLINICAL PRACTICE Chairman: G. Gasbarrini (Italy)

Probiotics and activity against intestinal viral pathogens: rationale and preliminary in vitro analysisM. Clementi (Italy)

Management of microbial intestinal ecology by biotherapeutic agentsL. Morelli (Italy) - S. Soldi (Italy)

Therapy of small bowel bacterial overgrowthA. Gasbarrini (Italy)

Probiotics and irritable bowel sindrome: rationale and clinical evidence for their useG. Barbara (Italy)

18

Tuesday, September 18 - aul a magna

09.00 - 10.30 a.m. INTERACTION OF THE ORAL AND GUT MICROBIOTA WITH THE HOST AND ITS IMMUNE SYSTEM Chairpeople: A. Onderdonk (USA) – L. Quercia Vieira (Brazil)

The role of polysaccharidic capsule in the interaction of Streptococcus gordonii with the host immune systemG. Pozzi (Italy)

Probiotics protect mice against experimental infectionsL. Quercia Vieira (Brazil)

The mechanisms involved in the intestinal interaction between host and bifidobacteria P. Brigidi (Italy)

Use of VSL # 3 probiotic mixture for prevention and therapyof allergic diseases: studies in mouse models of allergic sensitization to inhalant and food allergensG. Di Felice (Italy) – M. Boirivant (Italy)

10.30 - 12.30 a.m. HEALTH PROMOTING EFFECTS OF PROBIOTICS: UNDERSTANDING OF MECHANISMS Chairpeople: G. Famularo (Italy) – S. Kamiya (Japan)

Health, probiotics and inflammationE. Mengheri (Italy)

Probiotics and production of nitric oxideT. Midtvedt (Sweden)

Response of resident gut bacteria to the application of probiotics or prebioticsK. Scott (U.K.)

Effect of the probiotic agent Clostridium butyricum M 588 strain on enteric pathogensS. Kamiya (Japan)

Probiotics and gut functions: mechanisms of actionV. Theodorou (Greece)

19

Tuesday, September 18 - aul a newman

1) Histamine producing throat bacteria in the children with bronchial asthma (BA)V.A. Aleshkin, E.A.Voropaeva, B.A. Shenderov, G.N. Gabrichevsky (Russia)

2) Real-time PCR for rapid detection of probiotic lactobacilli in fermented milksL. Aquilanti, S. Santarelli, G. Silvestri, F. Clementi (Italy)

3) Probiotic properties of human Lactobacillus, Streptococcus and Bacillus strains to be used inthe gastrointestinal tractW. Baffone, R. Campana, V. Patrone, E. Vittoria, G.F. Donelli (Italy)

4) Growth Lactobacillus Plantarum P17630 on whey based mediaD. Barile, P. Malfa, J.D. Coisson , F. Travaglia, M. Arlorio (Italy)

5) Screening Combinations of Possible Novel Prebiotic Substrates in a Single Stage AnaerobicFermenter System to Assess the Affect on the Gut MicrofloraE. Beards, K. M. Tuohy, Glenn R. Gibson (United Kingdom)

6) Evaluation of microbial contamination of old toothbrushes and the survival rate at differentozone times? a pilot studyS.M. Cretoiu, M. Moldoveanu, A. Alexopoulos, V. Lazar, E. Bezirtzoglou (Romania)

7) Quantification of three probiotic strains in OTC product Linex by Real-time PCR:optimisation of sample preparation and amplification conditionsB. Bogovic Matijasic, T. Obermajer, I. Rogelj (Slovenia)

8) Epidemiology of Irritable Bowel Syndrome: role of fybers T. Casetti (Italy)

9) Effect of repeated in vivo passage (in mice) on SalmonellaA. Chatti, D. Daghfous, A. Landoulsi (Tunisia)

10) Specific probiotic strains and their combinations counteract adhesion of Enterobactersakazakii to intestinal mucusM.C. Collado, E. Isolauri, S. Salminen (Finland)

11) Use of a three-stage continuos culture system to study the impact of the whole grain cerealson the human gut microfloraA. Costabile, A. Klinder, C. Leonard, K.M. Tuohy, G.R. Gibson (United Kingdom)

12) Probiotics and prebiotics to control salmonella typhimurium in farm animalsS. Martín-Peláez, R.M. La Ragione, M.J. Woodward, R.A. Rastall1, G.R. Gibson,A. Costabile(Spain)

13) Gastrointestinal effects of immature wheat grain fructo-oligosaccharidesM.C. Casiraghi, M.G. D'Egidio, C. Cecchini, L. Benini, F. De Iorio, M.A. Pagani,E. Canzi, R. Zanchi (Italy)

14) Effects of different probiotic formulations on travelers diarrhea model in ratsH. Durand, J.F. Bisson (France)

20

POSTERS

15) Prebiotics for prevention of Listeria infectionsT. Ebersbach, A. Wilcks, M. Poulsen, T.R. Licht (Denmark)

16) Probiotic fruit juices: growth performances of selected lactobacilliM. Elli, E. Bessi, D. Cattivelli, S. Soldi, L. Morelli (Italy)

17) Lactobacillus sobrius DSM 16698 protects intestinal cells from enterotoxigenicEscherichia coli K88 through inhibition of pathogen adhesion and maintenance of IL-10mediated membrane barrier integrityM. Roselli, A. Finamore, M.S. Britti, S.R. Konstantion, H. Smidt, W.M. de Vos,E. Mengheri (Italy), (The Netherlands)

18) Influence of antibiotics on sheep raw milk qualityK. Fotou, A. Tzora, C. Acrida- Demertzi, C. Voidarou, A. Alexopoulos, E. Bezirtzoglou,P. Demertzis (Greece)

19) A comparative study on the safety of enterococci from different sourcesA. Gálvez, H. Abriouel, N. Ben Omar, A. Cobo, R.L. López, Ma J. Grande,P. Martínez-Viedma, E. Ortega, A. Sánchez, M. Martínez Canamero (Spain)

20) The viability of Lactobacillus fermentum is not essential in its intestinal anti-inflammatoryactivity in the TNBS model of rat colitisJ.Gálvez, L. Perán, M.E. Rodríguez-Cabezas, M. Comalada, E. Bailon, D. Camuesco,B. Arribas, M. Olivares, J. Xaus, A. Zarzuelo (Spain)

21) Discovery and characterisation of carbohydrate-interacting enzymes and proteins in twocommercial probioticsO. Gilad, B. Stuer-Lauridsen, B. Svensson, S. Jacobsen (Denmark)

22) Viability of bifidobacterium sp. in a symbiotic cream spreadM. Granito, Y. Valero, I. M. Reveron, R. Zambrano, J. Guinand (Venezuela)

23) Preparation of a polyfunctional fermented food productS. Guglielmetti, I. De Noni, F. Molinari, C. Parini, D. Mora (Italy)

24) Identification of an adhesion promoting lipoprotein in bifidobacterium bifidumS. Guglielmentti, I. Tamagnini, D. Mora, L. Minuzzo, A. Scarafoni, J. Hellman, M. Karp,C. Parini (Italy), (Finland)

25) Administration of rose hip and Lactobacillus plantarum DSM 9843 reduces lipidperoxidation after colonic ischemia in miceA. Hâkansson, G. Molin, S. Ahrné (Sweden)

26) Molecular investigation of the influence of oral fed Lactobacillus reuteri on the gutmicrobiota of HIV infected infants? a preliminary studyM. Handschur, A. Halsberger, L. Boltzmann (Austria)

27) Molecular analysis of naturally occurring bacterial communities in the phyllosphere of lettuceJ. Zwielehner, M. Handschur, R. Thaler, S. Irez, M. Demel, E.B.M. Denner, A.G.Haslberger (Austria)

21

POSTERS

28) The effect of spray drying on the probiotic efficacy of Lactobacillus sp.P.H. Ho, M.C. Adams, T.M. Le (Australia)

29) In vitro fermentation by human faecal microflora of wheat arabinoxylansS.A. Hughes, P.R. Shewry, L. Li, G.R. Gibson, M.L. Sanz, R.A. Rastall (United Kingdom-Spain)

30) Colonisation of selected lactobacilli strain in healthy volunteersP. Hütt, J. Stsepetova, I. Smidt, M. Mikelsaar (Estonia)

31) Whole grain wheat. A prebiotic ?

A. Klinder, A. Costabile, F. Fava, A. Napolitano, V. Fogliano, C. Leonard, G.R. Gibson,K.M. Tuohy (United Kingdom), (Italy)

32) Characterization of dominant cultivable lactobacilli and their antibiotic resistance profilesfrom fecal samples of weaning pigletsJ.M. Korhonen, Y. Sclivagnotis, A. von Wright (Finland)

33) Effects of novel nanostructured biomaterials on the adhesion and biofilm formation ofdifferent microbial strains in vitroV. Lazar (Romania)

34) Consumption of apples and apple pectin changes the rat caecal microbiotaA. Wilcks, M. Poulsen, B. Madsen, L. Ove Dragsted, T.R. Licht (Denmark)

35) The human biota associated rat as a model for the human intestinal microbiotaT.R. Licht, A. Wilcks (Denmark)

36) Analysis of the faecal bacterial populations of Irritable Bowel Syndrome patients withmolecular methodsE. Malinen, A. Kassinen, L. Krogius, T. Rinttilä, P. Auvinen, L. Paulin, H. Mäkivuokko, K.Kajander, A. Palva (Finland)

37) Detection of Actinobacteria associated with the human faecal microbiotaA.L. McCartney, L. Hoyles (United Kingdom)

38) Lactobacillus rhamnosus GG induces antigen-specific hyporesponsiveness in mesentericlymph-nodes lymphocytes of rats immunized with ovalbumin mediated by IL-10-producingregulatory T cellsE. Mengheri, M.S. Britti, N. Merendino, A. Finamore, M. Roselli, G. Tomassi (Italy)

39) Impact of a functional food containing FOS, on the gut microflora of healthy volunteers: arandomised, double-blind, placebo control trialE. Mitsou, K. Turunen, P. Anapliotis D. Zisi, A. Kyriacou (Greece)

40) Purification of fructo-oligosaccharides by adsorption onto charcoal filtersC. Nobre, A. Dominguez, D. Torres, O. Rocha, L. Rodrigues, I. Rocha, J.A. Teixeira, E.C. Ferreira (Portugal)

41) Removal of cyanobacterial toxins by specific strains of Probiotic bacteriaS.M.K. Nybom, S.J. Salminen, J.A.O. Meriluoto (Finland)

22

POSTERS

42) Genotypic and/or phenotypic characterization of clostridium difficile clinical isolates andevaluation of antagonistic effect of clostridium butyricumK. Oka, T. Osaki, T. Hanawa, S. Kurata, M. Okazaki, T. Manzoku, M. Takahashi,M. Tanaka, H. Taguchi, T. Watanabe, T. Inamatsu, S. Kamiya (Japan)

43) Administration of Lactobacillus plantarum DSM 9843 or DSM 15313 and rose hip to ratswith experimental induced colitis reduce the disease activity index, lipid peroxidationand improve the barrier effectsN. Osman, S. Ahrné, G. Molin, D. Adawi, B. Jeppsson, K. Rumpunen, A. Ekholm (Sweden)

44) Development of vegetable based probiotic food applying mixed cultureI. Perger-Meszaros, S. Kun, Z. Zalan, J. Rezessy-Szabo (Hungary)

45) Prebiotics for prevention of salmonella infectionsA. Petersen, A. Wilcks, M. Poulsen, T.R. Licht (Denmark)

46) Viability of aeromonas hydrophila on increasing concentrations of sodium chloride atdifferent temperaturesA. Pianetti, A. Manti, P. Boi, B. Citteio, L. Sabatini, S. Papa, F. Bruscolini (Italy)

47) Biofilm formation by strains of legionella pneumophila type 1 in static conditionsA. Pianetti, B. Citterio, E. Guaglianone, L. Pierfelici, L. Sabatini, G. Piersanti,F. Bruscolini,G. Donelli (Italy)

48) Comparative study of fermentative sugars and protein expression patterns of twolactobacillus plantarum strains grown in three different mediaC. Plumed-Ferrer, K.M. Koistinen, T.L. Tolonen, S.J. Lehesranta, S.O. Kärenlampi,E. Kilpi,V. Joutsjoki, V. Virtanen, A. von Wright (Finland)

49) Antagonistic activity of Lactobacillus rhamnosus GG against cell invasion by macrolide-and tetracycline-resistant group a streptococciM.S. Princivalli, C. Paoletti, C. Palmieri, L. Ferrante, B. Facinelli (Italy)

50) Red wine components affecting adhesive properties and biofilm formation by cariogenic streptococciF. Bianchi, M. Stauder, G. Giusto, F. Sivieri, A. Papetti, M. Daglia, B. Repetto, C.Signorotto, C. Pruzzo (Italy)

51) Bifidogenic nature of purified human milk oligosaccharides in mixed cultures of infantfaecal microfloraS. Qing, K. Tuohy, A.L. McCartney, G. Gibson, R. Ward (United Kingdom)

52) Investigation of the bacterial succession of the infant faecal microbiotaL.C. Roger, M.J. Kullen, A.L. McCartney (United Kingdom)

53) Probiotic bacteria in food supplement products available in ItalyA. Fiore, M. Casale, C. Scalfaro, P. Aureli (Italy)

54) Probiotic bacteria in food supplement products available in Italy (part 2: PCR-basedidentification)P. Aureli, C. Scalfaro, A. Fiore, M. Casale, G. Franciosa (Italy)

23

POSTERS

55) Mechanisms of L. salivarius CECT5713 interfering Salmonella infectionS. Sierra, L. Sempere, M.P. Díaz-Ropero, F. Lara-Villoslada, J. Xaus, M. Olivares (Spain)

56) Safety assessment of an antimicrobial synbiotic cheeseE. Songisepp, M. Rätsep, S. Köljalg, K. Truusalu, I. Smidt, R.H. Mikelsaar, J. Stsepetova,M. Mikelsaar (Estonia)

57) Antagonistic activity of clostridium butyricum against salmonella serovar enteritidis in vitroand in vivoM. Takahashi, T. Osaki, T. Hanawa, S. Kurata, K. Oka, H. Taguchi, S. Kamiya (Japan)

58) Probiotics reduce oxidative stress and pro-inflammatory markers in liverF. Lutgendorff, L.M. Trulsson, L.P. van Minnen, G.T. Rijkers, H.M. Timmerman,H.G. Gooszen, J.D. Söderholm, L.M.A. Akkermans, P.A. Sandström (Netherlands)

59) Seminal microflora of healthy young menS. Türk, M. Punab, P. Korrovits, K. Ausmees, R. Mändar (Estonia)

60) Efficacy of Bacillus subtilis strain PB6 in a rat model of inflammatory bowel diseaseJ. Van hemel, E. Peys, J. Vandenkerckhove, C.N. Ramchand, B. Sas (Belgium)

61) Comparative study of metabolites of Bacillus subtilis PB6 and other probiotics active againstclostridium difficileJ. Vandenkerckhove, J. Van hemel, E. Peys, B. Sas (Belgium)

62) Identification of Lactobacillus plantarum cell-wall proteins involved in host-microbeinteractionV. Vastano, C. Castaldo, L. Muscariello, C. Marino, M. Sacco (Italy)

63) The genome sequence insights of Bifidobacterium dentium BD1: a human oral commensalbacteriumM. Ventura, C. Canchaya, F. Turroni, A. Ribbera, E. Foroni, G.F. Fitzgerald, D. van Sinderen (Italy), (Ireland)

64) The tandem β-zipper model defines high affinity fibronectin-binding repeats withinstaphylococcus aureus FNBPAL. Visai, S. Rindi, N.A.G. Meenan, J.R. Potts, P. Speziale (Italy)

65) Role of probiotics in acute pancreatitis: a systematic reviewG. Capurso, M. Marignani, G.F. Delle Fave (Italy)

66) Resistance of probiotics to human secretionM. Del Piano (Italy)

67) A randomized controlled trial comparing early enteral nutrition containing probiotics versustotal parenteral nutrition after total proctocolectomy for ulcerative colitisK. Takahashi, Y. Funayama, K. Fukushima, C. Shibata, K. Miura, T. Kobayashi, H. Ogawa, T. Ueno, M. Kinouchi, A. Oyama, K. Kudo, A. Kohyama, K. Hayashi, I. Sasaki, T. Okamoto,N. Inamura, Y. Umesaki (Japan)

24

POSTERS

AAbrams S.H., USA 7Agostoni Carlo, Italy 10, 11Aleshkin Vladimir A., Russia 5Amil Dias Jorge, Portugal 11Andriulli Angelo, Italy 15Averna Maurizio, Italy 9

BBarbara Giovanni, Italy 18Berni Canani Roberto, Italy 10, 11Bertazzoni Minelli Elisa, Italy 5Bezirtzoglou Eugenia, Greece 8 Biasco Guido, Italy 6Blandino Giovanna, Italy 5Boirivant Monica, Italy 19Brigidi Patrizia, Italy 14, 19Buccigrossi Vittoria, Italy 10

CCamilleri Michael, USA 7Cannella Carlo, Italy 4Caporaso Nicola, Italy 9Caprilli Renzo, Italy 6Caprioli Flavio, Italy 6Capurso Lucio, Italy 4Castellazzi Anna Maria, Italy 11Cicero Arrigo F.G., Italy 9Ciprandi Guido, Italy 11Clementi Massimo, Italy 18Collignon Anne, France 7Connolly Eamonn, Sweden 11Coppa Giovanni V., Italy 10Corazza Gino R., Italy 8Cornaglia Giuseppe, Italy 4Costabile Adele, U.K. 9Crespi Massimo, Italy 6Cricelli Claudio, Italy 7

26

FACULT Y

27

facult y

DD’Amato Mauro, Italy 6Danese Silvio, Italy 6D’Argenio Giuseppe, Italy 9De Vincenzi Massimo, Italy 8De Vos Willem M., The Netherlands 6Decsi Tamas, Hungary 10Dellaglio Franco, Italy 4Delle Fave Gianfranco, Italy 4Del Piano Mario, Italy 8De Virgiliis Chiara, Italy 7Di Felice Gabriella, Italy 19Donelli Gianfranco, Italy 4, 8Doré Joel, France 6Drago Lorenzo, Italy 8

FFamularo Giuseppe, Italy 19Fanaro Silvia, Italy 10Fedorak Richard, Canada 7Fogliano Vincenzo, Italy 9

GGaraci Enrico, Italy 4Gasbarrini Antonio, Italy 18Gasbarrini Giovanni, Italy 18Gassull D. Miguel, Spain 6Gianfranceschi Gian Luigi, Italy 5Grompone Gianfranco, France 18Grossi Enzo, Italy 6Guaglianone Emilio, Italy 8Guarino Alfredo, Italy 10Guslandi Mario, Italy 7

HHeczko Piotr, Poland 8Hernell Olle, Sweden 10

IIsolauri Erika, Finland 11

JJacob Stefan, France 18Jacobsen Bodil Lund, Denmark 5

KKamiya Shigeru, Japan 19Klaenhammer Todd R., USA 6Koch Maurizio, Italy 7Koletzko Berthold, Germany 10

LLifschitz Carlos, USA 10Lionetti Elena, Italy 11Lupattelli Graziana, Italy 5

MMacfarlane Sandra, U.K. 8Madsen Karen, Canada 7Marotta Francesco, Italy 5, 7Mastrantonio Paola, Italy 7Mastromarino Paola, Italy 8Matteuzzi Diego, Italy 5Mattila-Sandholm Tiina, Finland 6Mengheri Elena, Italy 19Mercenier Annick, Switzerland 6Midtvedt Tore, Sweden 4, 8, 19Mihatsch Walter, Denmark 10Mikelsaar Marika, Estonia 5, 14Miraglia del Giudice Michele, Italy 11, 12Mogna Luca, Italy 11Molin Soeren, Denmark 8Morelli Lorenzo, Italy 4, 6, 8, 18Morisco Filomena, Italy 9

NNorin Elisabeth, Sweden 8, 16

OOggioni Marco Rinaldo, Italy 8Onderdonk Andrew Bruce, USA 10, 19

PPallone Francesco, Italy 6Paoluzi Paolo, Italy 15Patrignani Paola, Italy 5Peña Amado S., The Netherlands 7Pineiro Maya, FAO – Italy 4Poli Giuseppe, Italy 9

28

Facult y

29

Facult y

Porrini Marisa, Italy 9Pozzi Gianni, Italy 19Prakash Dubey Anand, India 11Prantera Cosimo, Italy 6Pruzzo Carla, Italy 8, 16

QQuercia Vieira Leda, Brazil 19

RRastall Robert A., USA 9Reid Gregor, Canada 8Remigy Michel, France 18Rescigno Maria, Italy 6Roda Enrico, Italy 9Romano Marco, Italy 6

SSaarela Maria, Finland 7Saggioro Alfredo, Italy 6Salvini Filippo, Italy 18Scott Karen, U.K. 7, 19Serafini Mauro, Italy 5Shenderov Boris A., Russia 5Silano Mauro, Italy 8Soldi Sara, Italy 18Somoza Veronika, Germany 9Spera Giovanni, Italy 9Stanghellini Vincenzo, Italy 18

TTynkkynen Soile, Finland 6Theodorou Vassilios, Greece 19

VVentura Marco, Italy 5Vigi Vittorio, Italy 10Vitaglione Paola, Italy 9

GENERAL INFORMATION• Oral communication session are scheduled as follows:

a) PEDIATRIC STUDIES: September 17 2007 AULA C from 06.00 to 07.00 p.m.b) EXPERIMENTAL STUDIES (I): September 17 2007 AULA D from 08.30 to 10.30 a.m.c) CLINICAL STUDIES: September 17 2007 AULA D from 11.00 to 11.30 a.m.d) EXPERIMENTAL STUDIES (II): September 17 2007 AULA D from 03.00 to 05.00 p.m.

• Posters authors are kindly requested to be present at the poster area on September 17 at • 01.00 - 02.30 a.m. to show their own poster.

DICOFARM - AG PHARMA PRIZEThe two best oral communications & two best posters will be selected. The winners will receivea prize of € 500,00 each kindly offered by Dicofarm - AG Pharma.

SLIDE CENTERAll speakers and authors must deliver their presentation (CD Rom, pen drive) at least 2 hoursin advance to the slide center (FIRST FLOOR main building).

LANGUAGEThe official language of the Meeting is English.

REGISTRATION FEES (20% VAT incl.)Participants Euro 600,00Under 35* Euro 324,00SOMED Delegates Euro 194,40Pediatric Day only Euro 240,00Daily Registration Euro 200,00Accompanying Person Euro 290,00Gala dinner (September 17) Euro 144,00*the applicant’s registration form must be accompanied by a copy of an official document.

REGISTRATION FEES INCLUDE:• Participants/Under 35:

Admission to Scientific Sessions, technical exhibition, satellite symposia, final programme, proceedings and abstract book, coffee breaks and lunch, opening ceremony and welcome cocktail, certificate of attendance.

CMEThe Scientific Committee has obtained Italian Continuing Medical Education credits inconjunction with participation in the educational meetings:

• 13 credits for the Congress• 6 credits for Pediatric Day • 6 credits for nurses

CERTIFICATE OF ATTENDANCEThe certificate of attendance will be given to all rgistered participants at the organizingsecretariat desk at the end of the Meeting.

VENUEUniversità Urbaniana – Terminal Gianicolo Via Urbano VIII - 00165 Rome – Italy

30

SC IENT IF I C INFORMAT ION

31

general INFORMAT ION

ORGANIZING SECRETARIAT DESK AT THE MEETING VENUE WILL BE OPEN AT: DAY DATE FROM TOSunday September 16 12.00 a.m. 07.00 p.m.Monday September 17 07.45 a.m. 06.30 p.m.Tuesday September 18 07.45 a.m. 01.00 p.m.

COFFEE BREAKS AND LUNCHLunch will be served free of charges at the catering area to participants wearing namebadge. A coffee corner will be open during the Meeting free of charge.

PARKING:Cars could be parked at Terminal Gianicolo. Participants to the meeting will have a specialrate. To obtain it, please contact the organizing secretariat desk.

FOR FURTHER INFORMATION, PLEASE CONTACT:

e meeting&consultingVia F. Denza, 19/A00197 RomaTel 0680693320Fax 0680692586probiotici2007@emec-roma.comwww.probiotics-prebiotics-newfood.orgwww.emec-roma.com

eMEETING&CONSULTING

32

sponsors

THIS MEETING WAS MADE POSSIBLE THANKS TO THE CONTRIBUTION PROVIDE BY:

AAT - ADVANCED ANALYTICAL TECHNOLOGIESACQUA E TERME DI ULIVETO

AG PHARMAALFA WASSERMANN

BIOACTIVALBIOCODEX BRACCO

CHR. HANSENCENTRO SPERIMENTALE DEL LATTE

DANONEDICOFARM

GRUPPO GRANAROLOIBSS BIOMEDITALCHIMICI

INSTITUT ROSELL-LALLEMANDLABOREST ITALIALONZA LTD BASEL

MEDIBASEMERCK SHARP & DOHME

NATHURANESTLÈ

NOVARTIS CONSUMER HEALTHNOOS

PARMALATPEGASO

PROBIOTICALRISO SCOTTI

SANOFI AVENTISS.I.I.T.SOFAR

SPECCHIASOLVALIO

VSL PHARMACEUTICALSYAKULT ITALIA

ZAMBON ITALIA